Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review.
about
Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of the LiteratureEribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.The Key Role of Sulfation and Branching on Fucoidan Antitumor Activity.Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.
P2860
Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Extending the duration of firs ...... cancer: a perspective review.
@ast
Extending the duration of firs ...... cancer: a perspective review.
@en
type
label
Extending the duration of firs ...... cancer: a perspective review.
@ast
Extending the duration of firs ...... cancer: a perspective review.
@en
prefLabel
Extending the duration of firs ...... cancer: a perspective review.
@ast
Extending the duration of firs ...... cancer: a perspective review.
@en
P2860
P356
P1476
Extending the duration of firs ...... t cancer: a perspective review
@en
P2093
Davide Corradengo
Mauro D'amico
P2860
P304
P356
10.1177/1758834011413423
P577
2011-09-01T00:00:00Z